Kestra Advisory Services’s Axsome Therapeutics AXSM Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-5,053	Closed	-$454K	–	2662
2024 Q3	$454K	Sell	5,053 -75	-1%	-$6.55K	﹤0.01%	1822
2024 Q2	$413K	Sell	5,128 -2,657	-34%	-$197K	﹤0.01%	1903
2024 Q1	$621K	Buy	7,785 +1,691	+28%	+$142K	﹤0.01%	1522
2023 Q4	$485K	Sell	6,094 -1,802	-23%	-$120K	﹤0.01%	1550
2023 Q3	$552K	Sell	7,896 -1,592	-17%	-$119K	0.01%	1318
2023 Q2	$682K	Sell	9,488 -314	-3%	-$23.2K	0.01%	1167
2023 Q1	$605K	Buy	9,802 +1,719	+21%	+$113K	0.01%	1184
2022 Q4	$623K	Sell	8,083 -2,134	-21%	-$128K	0.01%	1270
2022 Q3	$456K	Sell	10,217 -3,952	-28%	-$197K	﹤0.01%	1373
2022 Q2	$543K	Buy	14,169 +4,574	+48%	+$145K	0.01%	1289
2022 Q1	$397K	Buy	9,595 +3,341	+53%	+$104K	﹤0.01%	1416
2021 Q4	$236K	Sell	6,254 -130	-2%	-$4.78K	﹤0.01%	1772
2021 Q3	$210K	Buy	6,384 +784	+14%	+$30.6K	﹤0.01%	1947
2021 Q2	$378K	Buy	5,600 +1,627	+41%	+$97.6K	﹤0.01%	1428
2021 Q1	$225K	Buy	+3,973	New	+$279K	﹤0.01%	1656